We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XNCR icon
1101
Xencor
XNCR
$1.47B
$88K ﹤0.01%
2,290
-615
-21% -$25.1K
ACAD icon
1102
Acadia Pharmaceuticals
ACAD
$4.35B
$84K ﹤0.01%
+4,055
New +$63.8K
BTG icon
1103
B2Gold
BTG
$5.16B
$82K ﹤0.01%
35,899
NMR icon
1104
Nomura Holdings
NMR
$28.6B
$81K ﹤0.01%
16,957
+641
+4% +$3.04K
SPPI
1105
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$76K ﹤0.01%
4,624
+1,605
+53% +$34.7K
MUFG icon
1106
Mitsubishi UFJ Financial
MUFG
$260B
$75K ﹤0.01%
12,255
-419,079
-97% -$2.53M
NHY
1107
DELISTED
NORSK HYDRO A. S. ADR
NHY
$74K ﹤0.01%
+12,341
New +$74K
TEAM icon
1108
Atlassian
TEAM
$24.3B
$70K ﹤0.01%
742
+42
+6% +$3.33K
JBGS
1109
JBG SMITH
JBGS
$832M
$68K ﹤0.01%
1,850
C.PRC.CL
1110
DELISTED
Citigroup Inc.
C.PRC.CL
$68K ﹤0.01%
2,700
CNQ icon
1111
Canadian Natural Resources
CNQ
$93.4B
$64K ﹤0.01%
4,045
+251
+7% +$4.25K
CMD
1112
DELISTED
Cantel Medical Corporation
CMD
$64K ﹤0.01%
696
+70
+11% +$6.67K
WIT icon
1113
Wipro
WIT
$18.9B
$63K ﹤0.01%
+32,419
New +$62.5K
AEG icon
1114
Aegon
AEG
$13.5B
$61K ﹤0.01%
+11,126
New +$57.8K
ROG icon
1115
Rogers Corp
ROG
$2.31B
$61K ﹤0.01%
417
AUO
1116
DELISTED
AU Optronics Corp
AUO
$61K ﹤0.01%
+14,878
New +$63.3K
ARCC icon
1117
Ares Capital
ARCC
$13.6B
$58K ﹤0.01%
3,389
+123
+4% +$2.11K
DNKN
1118
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$56K ﹤0.01%
770
+3
+0.4% +$217
CCK icon
1119
Crown Holdings
CCK
$12.9B
$51K ﹤0.01%
1,067
ISBC
1120
DELISTED
Investors Bancorp, Inc.
ISBC
$49K ﹤0.01%
4,000
ATH
1121
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$49K ﹤0.01%
+960
New +$46.3K
MFG icon
1122
Mizuho Financial
MFG
$129B
$47K ﹤0.01%
+13,687
New +$47.8K
CSLT
1123
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$47K ﹤0.01%
+17,454
New +$61.7K
POLY
1124
DELISTED
Plantronics, Inc.
POLY
$46K ﹤0.01%
771
ATHX
1125
DELISTED
Athersys, Inc. Common Stock
ATHX
$46K ﹤0.01%
900

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.